30 Nov 2016 – By Aimee Robinson, Business Quarter
British healthcare company JRI Orthopaedics has strengthened its presence in China and the Far East after securing a new multi-million pound deal.
The company has secured regulatory approval to sell its hip product portfolio in China and has signed an exclusive distribution deal with China’s largest domestic orthopaedic producer, AK Medical.
The Chapeltown firm expects to sell a minimum of 10,000 hip implants in China over the next five years.
Keith Jackson, JRI Orthopaedics chief executive, said: “China has a population of 1.3 billion but currently only 250 million people have access to a hip replacement. The potential is huge and we see this as a significant market for the company.
“There is a really good appetite for high-quality, innovative British brands. Our proven, world class, precision manufacturing capabilities and efficiencies means we have defied convention to manufacture Chinese-designed products for the Chinese market here in Sheffield.
